Search results
Judge Frank Caprio announces he will be releasing a book
NBC 10 Providence· 6 days agoIn a social media post Monday morning, Caprio announced his plans for his first book. Titled...
Inside Out Wrecked Me — And Inside Out 2 Wrecked Me For Very Different Reasons - SlashFilm
/Film· 22 hours agoThis also meant that I was a sight for the poor minimum-wage worker who found an adult woman crying...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verastem, Inc. -...
Benzinga· 22 hours agoNEW YORK, June 15, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Verastem, Inc. ("Verastem" or the "Company") (NASDAQ:VSTM). Such investors are advised to contact
One Patient Changed This Onc's View of Hope. Here's How.
Medscape· 4 days agoOne Patient Changed This Oncologist's View of Hope. Following a stem cell transplant for leukemia,...
Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 191.7% in May
ETF DAILY NEWS· 3 days agoDominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,500 ...
AbbVie and FutureGen Announce License Agreement to Develop Next-Generation Therapy for Inflammatory...
The Port Lavaca Wave· 3 days ago- Global license agreement to focus on the development of FG-M701, a TL1A antibody, for the treatment of inflammatory bowel disease (IBD)
NC bill advances to force Chemours, others to pay for harm done to drinking water by PFAS
Durham Herald-Sun via Yahoo News· 4 days agoA Chemours representative asked that the bill not advance out of committee, saying the company built...
The reigning Miss America is an active-duty Air Force soldier with big dreams
The Post and Courier· 4 days agoIt’s a question Marsh works to answer every day. Now, she researches the disease to help improve ...
AbbVie inks deal to develop new IBD therapy with FutureGen By Investing.com
Investing.com· 3 days agoFG-M701, which is currently in the preclinical development stage, is designed as a fully human...
AB Science S.A. (OTCMKTS:ABSCF) Short Interest Up 5,200.0% in May
ETF DAILY NEWS· 3 days agoAB Science S.A. (OTCMKTS:ABSCF – Get Free Report) was the recipient of a significant increase in short interest during the month of May. As of May 31st, there was short interest totalling 26,500 ...